Akari Therapeutics Plc
AKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001541157
No open-market purchases or sales by Akari Therapeutics Plc insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.54M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Akari Therapeutics Plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −8 vs. Q2 2023
- Shares held
- 301.1K
- −202.7K (−40.2%) vs. Q2 2023Converted for a 1-for-20 split
- Total value
- $1.19M
- −$523.4K (−30.6%) vs. Q2 2023
- New holders
- 1
- 3 more added
- Sold out
- 9
- 1 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.54M |
| Q1 2026 | 6 | $308.2K |
| Q4 2025 | 21 | $1.29M |
| Q3 2025 | 16 | $1.18M |
| Q2 2025 | 15 | $644.3K |
| Q1 2025 | 11 | $377.3K |
| Q4 2024 | 14 | $393.8K |
| Q3 2024 | 10 | $535.9K |
| Q2 2024 | 10 | $488.1K |
| Q1 2024 | 8 | $326.3K |
| Q4 2023 | 9 | $891.6K |
| Q3 2023 | 8 | $1.19M |
| Q2 2023 | 16 | $1.71M |
| Q1 2023 | 12 | $1.84M |
| Q4 2022 | 15 | $4.19M |
| Q3 2022 | 14 | $6.37M |
| Q2 2022 | 14 | $1.68M |
| Q1 2022 | 11 | $1.89M |
| Q4 2021 | 11 | $2.16M |
| Q3 2021 | 14 | $1.99M |
| Q2 2021 | 12 | $2.27M |
| Q1 2021 | 15 | $3.90M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Akari Therapeutics Plc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 178,091 | $703.5K | 2.22% | −191,516−51.8% | ReducedConverted for a 1-for-20 split |
| Omnia Family Wealth, LLC | 59,117 | $233.5K | 0.14% | +19,998+51.1% | AddedConverted for a 1-for-20 split |
| Cerity Partners LLC | 23,643 | $93.4K | 0.00% | +7,500+46.5% | AddedConverted for a 1-for-20 split |
| NEA Management Company, LLC | 22,608 | $89.3K | 0.01% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 17,469 | $69.0K | 0.00% | +1,557+9.8% | AddedConverted for a 1-for-20 split |
| Bank of America Corp | 150 | $592 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Truvestments Capital LLC | 50 | $198 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Cornerstone Planning Group LLC | 5 | $20 | 0.00% | +5 | New |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −10,833−100.0% | Sold outConverted for a 1-for-20 split |
| LPL Financial LLC | 0 | $0 | 0.00% | −6,723−100.0% | Sold outConverted for a 1-for-20 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −6,702−100.0% | Sold outConverted for a 1-for-20 split |
| Hikari Power Ltd | 0 | $0 | 0.00% | −6,541−100.0% | Sold outConverted for a 1-for-20 split |
| WSFS Capital Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,513−100.0% | Sold outConverted for a 1-for-20 split |
| UBS Group AG | 0 | $0 | 0.00% | −1,223−100.0% | Sold outConverted for a 1-for-20 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −822−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −881−100.0% | Sold outConverted for a 1-for-20 split |